TNF and Insulin resistance: From the preceding discussion, we presume that ECD and LGZGD significantly not only inhibit TNF-α, NF-κB, and IRS-1Ser307 phosphorylation expression and improve insulin resistance but also decrease free fatty acids released by adipose tissue lipolysis and then decrease hepatic de novo lipogenesis and fat accumulation (Figure 7).